Member Info for Ollieh

Amazing price that to raise at....wow.

So big conference from the market .

Now on we go.

Yet aging finished up after hours.

Keeps on giving.

First day since data out that we went sideways.

24 didn't hold so is 20ish good for now?

Let's see.

True dd.

Best take it and run for now.

I'm contemplating 100% sell here myself .

It's a hard one at this stage as surly funding and the wait to trials in USA is going to see a natural drop somewhat.

Timing as usual is impossible to get right.

True EP.

Long way to go before it clears fda trials and on to market.

Us market different from aim i think but there must be profit taking soon I'd say.

Needs to find its balance now.

My plan is changing as the sp goes up.

I'm more used to uk/aim dealing.

Us market seems more forward thinking as regards future potential.

They like a winner.

Https://finance.yahoo.com/news/mrk-stock-dips-smmts-cancer-141100565.html

Probably some Mercks money coming over too.

Looks like we got legs again.

Great to see this after yesterday's climb. 👍

Pre market

https://www.fool.com/terms/p/premarket-trading/#:~:text=Premarket%20trading%20used%20to%20be,hours%20trading%20to%20retail%20investors.&text=Premarket%20trading%20takes%20place%20before,ahead%20of%20the%20market%20open.

Just some gut feeling in the context of how it has risen and time to next news.

Pre-market is a good indicator most of the time but not all.

Some sideways action with profit taking is to be expected, I'd settle for a calm hold and to not

go under $16 now going forward....hopefully

Https://finance.yahoo.com/news/summit-therapeutics-buy-now-082700426.html

Looks like some profit taking today

Might sell 60% and take a free ride to the end.

Getting on myself so 2030 is ok if on a free run .

If you have doubled your money take your initial money out with a little bonus , then forget about it until trials news.

Just my view.

Tomorrow and the rest of this week will tell the story mid term.

I doubt we will be able to hold this high for long, as the next stage here is funding and after that a while to trials ending and results.

Remember if all goes well this drug will go on sale around 2030.

Rocket 🚀 now

Fda has scope for speeding up the process on the back of that data.

But let's see where this goes.

Can't imagine that there won't be some profit taking.

True EP .

This will be some price in a few years , much more that $30 I think.

But 30 is ok target for now

Fda and European equivalent to go yet, that's few years away.

But if all positive this could be a big share price indeed .

Only thing now is funding and where it's raised.

+40% pre market

Let's hope it can stay strong on opening

Well done all who held 👏

Https://finance.yahoo.com/news/ivonescimab-monotherapy-reduced-risk-disease-154500133.html